Australian Mercantile Collections

Is ADMA Biologics (NASDAQ:ADMA) Using Too Much Debt?

Is ADMA Biologics (NASDAQ:ADMA) Using Too Much Debt?

Warren Buffett famously said, ‘Volatility is far from synonymous with risk.’ So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. As with many other companies ADMA Biologics, Inc. (NASDAQ:ADMA) makes use of debt. But the real question is whether this debt is making the company risky.

What Risk Does Debt Bring?

Debt assists a business until the business has trouble paying it off, either with new…

View the full article to continue reading…